SFM
AVEO

Sphera Funds Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Sphera Funds Management’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-130,000
Closed -$3.63M – 159
2017
Q4 		$3.63M Sell
130,000
-10,000
-7% -$310K 0.43% 57
2017
Q3 		$5.11M Sell
140,000
-80,000
-36% -$2.47M 0.73% 35
2017
Q2 		$4.88M Sell
220,000
-70,000
-24% -$551K 0.83% 30
2017
Q1 		$1.71M Buy
+290,000
New +$2.09M 0.33% 76

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Sphera Funds Management's AVEO Position: Q1 2018 in Review

Sphera Funds Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2018, closing a stake of 130,000 shares — an estimated $3.63M sold.

Sphera Funds Management first reported a position in AVEO in Q1 2017 and held it in 4 quarters. The position peaked at $5.11M in Q3 2017. 90 funds tracked by Wall St. Rank hold AVEO as of Q1 2018.

  • Sphera Funds Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Sphera Funds Management sold 130,000 AVEO Pharmaceuticals, Inc. shares in Q1 2018, an estimated $3.63M.
  • Sphera Funds Management first reported a position in AVEO Pharmaceuticals, Inc. in Q1 2017 and held it in 4 quarters.
  • Sphera Funds Management's AVEO Pharmaceuticals, Inc. position peaked at $5.11M in Q3 2017.
  • 90 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2018.

Based on Sphera Funds Management's 13F filing for Q1 2018, filed 10 May 2018.